| SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 5818 | 2013 |
| Initial invasive or conservative strategy for stable coronary disease DJ Maron, JS Hochman, HR Reynolds, S Bangalore, SM O’Brien, ... New England Journal of Medicine 382 (15), 1395-1407, 2020 | 1917 | 2020 |
| Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials C Axfors, AM Schmitt, P Janiaud, J Van’t Hooft, S Abd-Elsalam, EF Abdo, ... Nature communications 12 (1), 2349, 2021 | 336 | 2021 |
| SPIRIT 2013 Statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Revista Panamericana de Salud Pública 38, 506-514, 2015 | 296* | 2015 |
| Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind … EM Ohman, MT Roe, PG Steg, SK James, TJ Povsic, J White, F Rockhold, ... The Lancet 389 (10081), 1799-1808, 2017 | 229 | 2017 |
| Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia LF MARTIN, FVML BOOTH, RG KARLSTADT, JH SILVERSTEIN, ... Critical care medicine 21 (1), 19-30, 1993 | 165 | 1993 |
| Access to patient-level data from GlaxoSmithKline clinical trials P Nisen, F Rockhold New England Journal of Medicine 369 (5), 475-478, 2013 | 147 | 2013 |
| Guidelines for quality assurance in multicenter trials: a position paper GL Knatterud, FW Rockhold, SL George, FB Barton, CE Davis, ... Controlled clinical trials 19 (5), 477-493, 1998 | 146 | 1998 |
| Electronic health records, medical research, and the Tower of Babel RD Kush, E Helton, FW Rockhold, CD Hardison New England Journal of Medicine 358 (16), 1738-1740, 2008 | 118 | 2008 |
| Acute limb ischemia in peripheral artery disease: insights from EUCLID CN Hess, Z Huang, MR Patel, I Baumgartner, JS Berger, JI Blomster, ... Circulation 140 (7), 556-565, 2019 | 109 | 2019 |
| Myocardial infarction in the ISCHEMIA trial: impact of different definitions on incidence, prognosis, and treatment comparisons BR Chaitman, KP Alexander, DD Cyr, JS Berger, HR Reynolds, ... Circulation 143 (8), 790-804, 2021 | 90 | 2021 |
| Initial invasive versus conservative management of stable ischemic heart disease in patients with a history of heart failure or left ventricular dysfunction: insights from the … RD Lopes, KP Alexander, SR Stevens, HR Reynolds, GW Stone, IL Piña, ... Circulation 142 (18), 1725-1735, 2020 | 88 | 2020 |
| Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial L Bravo, I Smolenov, HH Han, P Li, R Hosain, F Rockhold, SAC Clemens, ... The Lancet 399 (10323), 461-472, 2022 | 83 | 2022 |
| Polyvascular disease and risk of major adverse cardiovascular events in peripheral artery disease: a secondary analysis of the EUCLID trial JA Gutierrez, H Mulder, WS Jones, FW Rockhold, I Baumgartner, ... JAMA network open 1 (7), e185239-e185239, 2018 | 82 | 2018 |
| Data sharing at a crossroads F Rockhold, P Nisen, A Freeman New England Journal of Medicine 375 (12), 1115-1117, 2016 | 69 | 2016 |
| Cardiovascular and limb outcomes in patients with diabetes and peripheral artery disease: the EUCLID trial CC Low Wang, JI Blomster, G Heizer, JS Berger, I Baumgartner, ... Journal of the American College of Cardiology 72 (25), 3274-3284, 2018 | 64 | 2018 |
| Reliever-triggered inhaled glucocorticoid in Black and Latinx adults with asthma E Israel, JC Cardet, JK Carroll, AL Fuhlbrigge, L She, FW Rockhold, ... New England Journal of Medicine 386 (16), 1505-1518, 2022 | 52 | 2022 |
| The current landscape in biostatistics of real-world data and evidence: causal inference frameworks for study design and analysis M Ho, M van der Laan, H Lee, J Chen, K Lee, Y Fang, W He, T Irony, ... Statistics in Biopharmaceutical Research 15 (1), 43-56, 2023 | 51* | 2023 |
| Ferric carboxymaltose in heart failure with iron deficiency RJ Mentz, J Garg, FW Rockhold, J Butler, CG De Pasquale, JA Ezekowitz, ... New England Journal of Medicine 389 (11), 975-986, 2023 | 50 | 2023 |
| Reporting the findings of clinical trials: a discussion paper D Ghersi, M Clarke, J Berlin, AM Gülmezoglu, R Kush, P Lumbiganon, ... Bulletin of the World Health Organization 86, 492-493, 2008 | 49 | 2008 |
